SXL
TMO icon

Summit X LLC’s Thermo Fisher Scientific TMO Stock Holding History

Summit X LLC’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-395
Closed -$216K – 233
2024
Q2 		$216K Buy
+395
New +$226K 0.05% 224
2023
Q3 		– Sell
-2,637
Closed -$1.38M – 267
2023
Q2 		$1.38M Buy
2,637
+98
+4% +$52.9K 0.33% 58
2023
Q1 		$1.46M Sell
2,539
-154
-6% -$86.8K 0.38% 51
2022
Q4 		$1.46M Sell
2,693
-71
-3% -$37.6K 0.42% 53
2022
Q3 		$1.4M Buy
2,764
+71
+3% +$39.7K 0.41% 58
2022
Q2 		$1.46M Sell
2,693
-69
-2% -$38K 0.42% 53
2022
Q1 		$1.63M Sell
2,762
-50
-2% -$28.7K 0.4% 52
2021
Q4 		$1.88M Sell
2,812
-10
-0.4% -$6.24K 0.44% 50
2021
Q3 		$1.61M Sell
2,822
-5
-0.2% -$2.74K 0.4% 56
2021
Q2 		$1.43M Sell
2,827
-14
-0.5% -$6.61K 0.36% 64
2021
Q1 		$1.3M Sell
2,841
-76
-3% -$36.3K 0.36% 66
2020
Q4 		$1.36M Buy
+2,917
New +$1.37M 0.4% 58
2020
Q2 		$1.09M Buy
3,000
+70
+2% +$23.5K 0.4% 65
2020
Q1 		$832K Sell
2,930
-15
-0.5% -$4.73K 0.39% 68
2019
Q4 		$953K Sell
2,945
-230
-7% -$69.7K 0.35% 70
2019
Q3 		$922K Sell
3,175
-5
-0.2% -$1.43K 0.37% 73
2019
Q2 		$940K Buy
3,180
+30
+1% +$8.26K 0.38% 67
2019
Q1 		$856K Buy
3,150
+265
+9% +$65.9K 0.37% 71
2018
Q4 		$640K Buy
2,885
+10
+0.3% +$2.35K 0.37% 77
2018
Q3 		$704K Sell
2,875
-20
-0.7% -$4.6K 0.35% 68
2018
Q2 		$591K Buy
2,895
+40
+1% +$8.49K 0.33% 78
2018
Q1 		$580K Buy
2,855
+75
+3% +$15.7K 0.35% 79
2017
Q4 		$522K Buy
2,780
+100
+4% +$19.2K 0.33% 85
2017
Q3 		$502K Buy
2,680
+105
+4% +$19K 0.33% 79
2017
Q2 		$443K Buy
+2,575
New +$433K 0.32% 98

Other funds holding TMO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Summit X LLC's TMO Position: Q3 2024 in Review

Summit X LLC sold out of Thermo Fisher Scientific (TMO) in Q3 2024, closing a stake of 395 shares — an estimated $216K sold.

Summit X LLC first reported a position in TMO in Q2 2017 and held it in 25 quarters. The position peaked at $1.88M in Q4 2021. 2,574 funds tracked by Wall St. Rank hold TMO as of Q3 2024.

  • Summit X LLC reported no remaining Thermo Fisher Scientific position as of Q3 2024 after selling out during the quarter.
  • Summit X LLC sold 395 Thermo Fisher Scientific shares in Q3 2024, an estimated $216K.
  • Summit X LLC first reported a position in Thermo Fisher Scientific in Q2 2017 and held it in 25 quarters.
  • Summit X LLC's Thermo Fisher Scientific position peaked at $1.88M in Q4 2021.
  • 2,574 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q3 2024.

Based on Summit X LLC's 13F filing for Q3 2024, filed 7 Nov 2024.